Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, January 12 '25)

Image
By G.M.

 


    BMJ

  1. KAST KA, Sidelnik SA, Nejad SH, Suzuki J, et al
    Management of alcohol withdrawal syndromes in general hospital settings.
    BMJ. 2025;388:e080461.
    PubMed         Abstract available


    Clin Infect Dis

  2. XIANG W, Steinbeis F, Dhindsa K, Kurth F, et al
    Predicting the risk of intensive care unit admission in patients with COVID-19 presenting in the emergency room: Development and evaluation of the CROSS score.
    Clin Infect Dis. 2025 Jan 10:ciaf006. doi: 10.1093.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  3. NAKASHITA M, Kurosawa K, Fukusumi M, Irie F, et al
    Improving the ability of psychiatric hospitals to respond to infectious disease outbreaks: lessons learned from the COVID-19 outbreak response in Ibaraki Prefecture, Japan.
    Infect Control Hosp Epidemiol. 2025 Jan 8:1-2. doi: 10.1017/ice.2024.
    PubMed        

  4. VAN REST A, Clarke A, Gounder P, Nie PK, et al
    COVID-19 outbreaks in nursing homes in Los Angeles County, March 2020-April 2022.
    Infect Control Hosp Epidemiol. 2025 Jan 7:1-7. doi: 10.1017/ice.2024.
    PubMed         Abstract available


    J Infect

  5. ONG DS, Harris M, Hart JD, Russell FM, et al
    Lack of correlation between school reopening and trends in adult COVID-19 hospitalisations and death rates during the Delta and early Omicron periods: an ecological analysis of five countries.
    J Infect. 2025 Jan 6:106390. doi: 10.1016/j.jinf.2024.106390.
    PubMed         Abstract available

  6. JORDA A, Prager M, Pracher L, Haselwanter P, et al
    Immunogenicity, Safety, and Reactogenicity of Concomitant Administration of the Novavax Vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged >/=60 Years: A Randomised, Double-blind, Placebo-contro
    J Infect. 2025 Jan 3:106405. doi: 10.1016/j.jinf.2024.106405.
    PubMed         Abstract available


    J Med Virol

  7. ZHANG S, Kong X, Zhen Q, Wei Y, et al
    Dynamic Changes and Trends of SARS-CoV-2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points.
    J Med Virol. 2025;97:e70161.
    PubMed         Abstract available

  8. KO C, Cheng CC, Mistretta D, Ambike S, et al
    SARS-CoV-2 Productively Infects Human Hepatocytes and Induces Cell Death.
    J Med Virol. 2025;97:e70156.
    PubMed         Abstract available


    J Virol

  9. GRIMES SL, Heaton BE, Anderson ML, Burke K, et al
    The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activity.
    J Virol. 2025 Jan 10:e0170824. doi: 10.1128/jvi.01708.
    PubMed         Abstract available

  10. ARORA P, Zhang L, Nehlmeier I, Kempf A, et al
    Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D.
    J Virol. 2025 Jan 10:e0123024. doi: 10.1128/jvi.01230.
    PubMed         Abstract available

  11. HU H, Leng C, Shu Y, Peng L, et al
    Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2.
    J Virol. 2025 Jan 7:e0130724. doi: 10.1128/jvi.01307.
    PubMed         Abstract available

  12. GUNAWARDENE CD, Wong L-YR
    Betacoronavirus internal protein: role in immune evasion and viral pathogenesis.
    J Virol. 2025 Jan 6:e0135324. doi: 10.1128/jvi.01353.
    PubMed         Abstract available


    Life Sci

  13. CHOPRA A, Franko N, Chow EJ
    Navigating neurologic post-COVID-19 conditions in adults: Management strategies for cognitive dysfunction, headaches and neuropathies.
    Life Sci. 2025;362:123374.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi

  14. SONG LC, Xie LX
    [Clinical update in critical care of pulmonary medicine 2024].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:84-89.
    PubMed         Abstract available

  15. LI SN, Ni WT, Li R, Chen YW, et al
    [Clinical characteristics of immunocompromised patients infected with COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:35-42.
    PubMed         Abstract available


  16. [Chinese expert consensus on the diagnosis and treatment of pneumonia in the elderly (2024 Edition)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:18-34.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#USA, Two more #human cases of #H5N1 #birdflu reported in #California

By G.M.
Two cases of bird flu have been reported in San Joaquin County, California, local health officials said. According to a press release issued Friday and reported by the Sacramento Bee , health officials with San Joaquin County Public Health Services said both cases were farm workers who were exposed to infected animals . Both people are showing mild symptoms and are recovering, officials said, adding that there are 34 total confirmed cases across California. In a warning posted on Facebook, health officials said bird flu was “spreading in several farms such as poultry and cattle” and urged residents to take precautions to prevent the spread of the disease. Precautions include the use of protective equipment when handling poultry, dairy cattle or other animals that may be infected, and when handling raw and unpasteurized milk. (...) There are currently 60 confirmed cases of bird flu in the country . While most of the cases are in California , other states with confirmed cases include Col...
Post a Comment
Read more »

Viral #sepsis: #diagnosis, clinical #features, #pathogenesis, and #clinical considerations

By G.M.
Abstract Sepsis , characterized as life-threatening organ dysfunction resulting from dysregulated host responses to infection , remains a significant challenge in clinical practice . Despite advancements in understanding host-bacterial interactions , molecular responses, and therapeutic approaches, the mortality rate associated with sepsis has consistently ranged between 10 and 16%. This elevated mortality highlights critical gaps in our comprehension of sepsis etiology. Traditionally linked to bacterial and fungal pathogens, recent outbreaks of acute viral infections , including Middle East respiratory syndrome coronavirus ( MERS-CoV ), influenza virus, and severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), among other regional epidemics, have underscored the role of viral pathogenesis in sepsis, particularly when critically ill patients exhibit classic symptoms indicative of sepsis. However, many cases of viral-induced sepsis are frequently underdiagnosed because standar...
Post a Comment
Read more »

Rapid #Surge of #Reassortant A(#H1N1) #Influenza Viruses in Danish #Swine and their #Zoonotic Potential

By G.M.
 Source: BioRxIV, https://www.biorxiv.org/content/10.1101/2024.12.11.627926v1?rss=1  Abstract In 2018, a single detection of a novel reassortant swine influenza A virus (swIAV) was made in Denmark . The hemagglutinin (HA) of the virus was from the H1N1 pandemic 2009 (H1N1pdm09) lineage and the neuraminidase (NA) from the H1N1 Eurasian avian-like swine lineage (H1N1av). By 2022, the novel reassortant virus (H1pdm09N1av) constituted 27 % of swIAVs identified through the Danish passive swIAV surveillance program. Sequencing detected two H1pdm09N1av genotypes ; Genotype 1 contained an internal gene cassette of H1N1pdm09 origin , Genotype 2 differed by carrying an NS gene segment of H1N1av origin . The internal gene cassette of Genotype 2 became increasingly dominant, not only in the H1pdm09N1av population, but also in other Danish enzootic swIAV subtypes . Phylogenetic analysis of the HA genes from H1pdm09N1av viruses revealed a monophyletic source , a higher substitution rat...
Post a Comment
Read more »